• 8 Citations
  • 1 h-Index
20172018
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Annalisa Martines is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 19 Similar Profiles
T-Cell Leukemia Medicine & Life Sciences
Catenins Medicine & Life Sciences
T-cells Chemical Compounds
Drug Discovery Medicine & Life Sciences
Multiple Myeloma Medicine & Life Sciences
Precursor Cell Lymphoblastic Leukemia-Lymphoma Medicine & Life Sciences
Cells Chemical Compounds
Cell Line Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2017 2018

  • 8 Citations
  • 1 h-Index
  • 4 Article

A Novel t(8;14)(q24;q11) Rearranged Human Cell Line as a Model for Mechanistic and Drug Discovery Studies of NOTCH1-Independent Human T-Cell Leukemia

Tosello, V., Milani, G., Martines, A., Macri, N., Van Loocke, W., Matthijssens, F., Buldini, B., Minuzzo, S., Bongiovanni, D., Schumacher, R. F., Amadori, A., Van Vlierberghe, P. & Piovan, E., Oct 9 2018, In : Cells. 7, 10, 10.3390/ce.

Research output: Contribution to journalArticle

T-Cell Leukemia
T-cells
Drug Discovery
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Cells

Splenic marginal zone lymphoma with a de novo t(8;14)(q24;q32) and a prolymphocytoid evolution responsive to rituximab-bendamustine

Scapinello, G., Pizzi, M., Vio, S., Nabergoj, M., Visentin, A., Martines, A., Bonaldi, L., Trentin, L., Semenzato, G. & Piazza, F., Oct 2018, In : Annals of Hematology. 97, 10, p. 2001-2003 3 p.

Research output: Contribution to journalArticle

Inactivation of CK1α in multiple myeloma empowers drug cytotoxicity by affecting AKT and ß-catenin survival signaling pathways

Manni, S., Carrino, M., Manzoni, M., Gianesin, K., Nunes, S. C., Costacurta, M., Tubi, L. Q., Macaccaro, P., Taiana, E., Cabrelle, A., Barilà, G., Martines, A., Zambello, R., Bonaldi, L., Trentin, L., Neri, A., Semenzato, G. & Piazza, F., 2017, In : Oncotarget. 8, 9, p. 14604-14619 16 p.

Research output: Contribution to journalArticle

8 Citations (Scopus)

Inactivation of CK1α in multiple myeloma empowers drug cytotoxicity by affecting AKT and ß-catenin survival signaling pathways

Manni, S., Carrino, M., Manzoni, M., Gianesin, K., Nunes, S. C., Costacurta, M., Tubi, L. Q., Macaccaro, P., Taiana, E., Cabrelle, A., Barilà, G., Martines, A., Zambello, R., Bonaldi, L., Trentin, L., Neri, A., Semenzato, G. & Piazza, F., 2017, In : Oncotarget. 8, 9, p. 14604-14619 16 p.

Research output: Contribution to journalArticle

Catenins
Multiple Myeloma
Survival
Plasma Cells
Pharmaceutical Preparations